252 related articles for article (PubMed ID: 34104303)
21. Epirubicin for breast cancer during pregnancy: a case report.
Eedarapalli P; Biswas N; Coleman M
J Reprod Med; 2007 Aug; 52(8):730-2. PubMed ID: 17879836
[TBL] [Abstract][Full Text] [Related]
22. Docetaxel followed by fluorouracil/epirubicin/cyclophosphamide as neoadjuvant chemotherapy for patients with primary breast cancer.
Iwata H; Sato N; Masuda N; Nakamura S; Yamamoto N; Kuroi K; Kurosumi M; Tsuda H; Akiyama F; Ohashi Y; Toi M
Jpn J Clin Oncol; 2011 Jul; 41(7):867-75. PubMed ID: 21719750
[TBL] [Abstract][Full Text] [Related]
23. Neonatal effects of breast cancer chemotherapy administered during pregnancy.
Kerr JR
Pharmacotherapy; 2005 Mar; 25(3):438-41. PubMed ID: 15843292
[TBL] [Abstract][Full Text] [Related]
24. [Breast cancers associated with pregnancy. About two cases].
Ndioubnane MD; Mahmoud GO; Bal A
Tunis Med; 2005 Jun; 83(6):375-7. PubMed ID: 16156417
[TBL] [Abstract][Full Text] [Related]
25. Cardiac assessment of early breast cancer patients 18 years after treatment with cyclophosphamide-, methotrexate-, fluorouracil- or epirubicin-based chemotherapy.
de Azambuja E; Ameye L; Diaz M; Vandenbossche S; Aftimos P; Bejarano Hernández S; Shih-Li C; Delhaye F; Focan C; Cornez N; Vindevoghel A; Beauduin M; Lemort M; Paesmans M; Suter T; Piccart-Gebhart M
Eur J Cancer; 2015 Nov; 51(17):2517-24. PubMed ID: 26321502
[TBL] [Abstract][Full Text] [Related]
26. Adriamycin and cyclophosphamide chemotherapy in advanced breast cancer in pregnancy.
Skrablin S; Banović V; Matković V
Eur J Obstet Gynecol Reprod Biol; 2007 Aug; 133(2):251-2. PubMed ID: 16860457
[No Abstract] [Full Text] [Related]
27. A single-center, randomized, parallel controlled study comparing the efficacy and safety aspects of three anthracycline-based regimens as neoadjuvant chemotherapy in primary breast cancer.
Zhou Y; Ouyang T; Xie Y; Wang T; Fan Z; He Y; Lu A; Liu Y; Li J
Breast Cancer Res Treat; 2016 Jun; 157(3):527-34. PubMed ID: 27250001
[TBL] [Abstract][Full Text] [Related]
28. A randomized phase 2 study comparing EC or CMF versus nab-paclitaxel plus capecitabine as adjuvant chemotherapy for nonfrail elderly patients with moderate to high-risk early breast cancer (ICE II-GBG 52).
von Minckwitz G; Conrad B; Reimer T; Decker T; Eidtmann H; Eiermann W; Hackmann J; Möbus V; Marmé F; Potenberg J; Stickeler E; Simon E; Thomssen C; Huober J; Denkert C; Alfer J; Jackisch C; Nekljudova V; Burchardi N; Loibl S;
Cancer; 2015 Oct; 121(20):3639-48. PubMed ID: 26111104
[TBL] [Abstract][Full Text] [Related]
29. Clinical comparison of safety and efficacy of vinorelbine/epirubicin (NE) with fluorouracil/epirubicin/cyclophosphamide (FEC).
Yan PW; Huang XE; Jiang Y; Tang JH; Xu HX; Xu X; Jin X
Asian Pac J Cancer Prev; 2010; 11(4):1115-8. PubMed ID: 21133634
[TBL] [Abstract][Full Text] [Related]
30. Treatment of pregnant breast cancer patients and outcomes of children exposed to chemotherapy in utero.
Hahn KM; Johnson PH; Gordon N; Kuerer H; Middleton L; Ramirez M; Yang W; Perkins G; Hortobagyi GN; Theriault RL
Cancer; 2006 Sep; 107(6):1219-26. PubMed ID: 16894524
[TBL] [Abstract][Full Text] [Related]
31. Intrapleural extravasation of epirubicin, 5-fluouracil, and cyclophosphamide, treated with dexrazoxane.
Uges JW; Vollaard AM; Wilms EB; Brouwer RE
Int J Clin Oncol; 2006 Dec; 11(6):467-70. PubMed ID: 17180516
[TBL] [Abstract][Full Text] [Related]
32. Chemotherapy for a patient with advanced non-small-cell lung cancer during pregnancy: a case report and a review of chemotherapy treatment during pregnancy.
Jänne PA; Rodriguez-Thompson D; Metcalf DR; Swanson SJ; Greisman HA; Wilkins-Haug L; Johnson BE
Oncology; 2001; 61(3):175-83. PubMed ID: 11574771
[TBL] [Abstract][Full Text] [Related]
33. Randomized trial comparing six versus three cycles of epirubicin-based adjuvant chemotherapy in premenopausal, node-positive breast cancer patients: 10-year follow-up results of the French Adjuvant Study Group 01 trial.
Fumoleau P; Kerbrat P; Romestaing P; Fargeot P; Brémond A; Namer M; Schraub S; Goudier MJ; Mihura J; Monnier A; Clavère P; Serin D; Seffert P; Pourny C; Facchini T; Jacquin JP; Sztermer JF; Datchary J; Ramos R; Luporsi E
J Clin Oncol; 2003 Jan; 21(2):298-305. PubMed ID: 12525522
[TBL] [Abstract][Full Text] [Related]
34. Dose-intensive epirubicin-based chemotherapy is superior to an intensive intravenous cyclophosphamide, methotrexate, and fluorouracil regimen in metastatic breast cancer: a randomized multinational study.
Ackland SP; Anton A; Breitbach GP; Colajori E; Tursi JM; Delfino C; Efremidis A; Ezzat A; Fittipaldo A; Kolaric K; Lopez M; Viaro D;
J Clin Oncol; 2001 Feb; 19(4):943-53. PubMed ID: 11181656
[TBL] [Abstract][Full Text] [Related]
35. [A case of recurring breast cancer causing pericardial metastasis showing a good response following local treatment with methotrexate].
Nakaguchi K; Furukawa J; Maruyama N; Nakamura M; Shingai T; Maruyama K; Katsumoto Y; Okajima S; Sue F; Yoshiwara W
Gan To Kagaku Ryoho; 2001 Oct; 28(11):1753-6. PubMed ID: 11708026
[TBL] [Abstract][Full Text] [Related]
36. Eclampsia after polychemotherapy for nodal-positive breast cancer during pregnancy.
Müller T; Hofmann J; Steck T
Eur J Obstet Gynecol Reprod Biol; 1996 Aug; 67(2):197-8. PubMed ID: 8841812
[TBL] [Abstract][Full Text] [Related]
37. Inflammatory breast cancer outcome with epirubicin-based induction and maintenance chemotherapy: ten-year results from the French Adjuvant Study Group GETIS 02 Trial.
Veyret C; Levy C; Chollet P; Merrouche Y; Roche H; Kerbrat P; Fumoleau P; Fargeot P; Clavere P; Chevallier B
Cancer; 2006 Dec; 107(11):2535-44. PubMed ID: 17054108
[TBL] [Abstract][Full Text] [Related]
38. [A case of advanced breast cancer leading to DIC after chemotherapy].
Ishizuka S; Morikawa T; Yoshida K; Nobuhisa T; Endo Y; Watanabe T; Matsumoto Y; Doi Y; Yamada T; Kai K; Nakashima A; Nagahiro I; Sato S; Nakashima A; Nabeyama A
Gan To Kagaku Ryoho; 2007 Nov; 34(11):1845-8. PubMed ID: 18030021
[TBL] [Abstract][Full Text] [Related]
39. Randomized trial of cyclophosphamide, epirubicin, and fluorouracil chemotherapy compared with cyclophosphamide, methotrexate, and fluorouracil with node-positive breast cancer in Japan.
Kimura M; Tominaga T; Takatsuka Y; Toi M; Abe R; Koyama H; Takashima S; Nomura Y; Miura S; Kimijima I; Tashiro H; Ohashi Y;
Breast Cancer; 2010 Jul; 17(3):190-8. PubMed ID: 19575284
[TBL] [Abstract][Full Text] [Related]
40. Trastuzumab use for metastatic breast cancer in pregnancy.
Sekar R; Stone PR
Obstet Gynecol; 2007 Aug; 110(2 Pt 2):507-10. PubMed ID: 17666645
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
